Hints and tips:
Related Special Reports
...Founded in 1978, CD&R is one of the oldest private equity firms. Its strategy is focused on trying to improve the operations of companies it owns....
...Since then, as well as agreeing to buy Presidio, it has made a series of large investments including buying snack company Shearer’s Foods. CD&R and BC Partners declined to comment....
...The manifesto called for “radical new action” to address key challenges, such as the need for more investment in creative R&D and reversing the decline in access to creative education as well as a revised...
...It has so far distributed about R$35.5bn ($7bn). The UK legal case, the country’s largest-ever class action, is due to start in October....
...Companies whose R&D claims have been rejected unexpectedly have been forced to change their business plans....
...Perhaps central banks are important in shaping R-star with their actions not words. If low interest rates create zombie companies that do not invest, it can lower R-star and be self-reinforcing....
...The annual jamboree is produced by Jay-Z’s entertainment company Roc Nation. The R&B singer has the stature for the marquee event....
...at which loss-making companies are taxed within the merged scheme from 25 per cent to 19 per cent and lower the threshold for the additional support for R&D intensive lossmaking firms....
...CD&R bought MFG for £500mn nearly a decade ago....
...In recent years, the company has sought to diversify through acquisitions. It bought personal finance company Credit Karma for $8.1bn in 2020 and email marketing provider MailChimp for $12bn in 2021....
...Nemer said committing to funding levels of $10bn-$15bn for R&D would be justified to tackle other pathogens....
...Together with Thomas R, they set up research projects between the company, German universities and sham Chinese business partners....
...R&Q: Shares in the London-listed insurer plummeted 45 per cent after the Bermuda-based company warned that it expected to “realise a significant pre-tax loss for the year”....
...Should companies be punished for handing money back to shareholders? The Department of Justice seems to think so....
...The company spent €6.7bn on R&D last year. It plans to spend an additional €700mn next year. That is not eye-popping. Sanofi’s R&D spend last year was 15.6 per cent of revenues....
...Stellantis’ announcement followed a meeting between executives and the leftist leader, the company said....
...“Although our R&D budget fell this year, we will provide utmost support for R&D spending next year, reflecting the reform results.”...
...It spent €6.7bn on R&D last year, up from about €5.5bn in 2020, and plans to spend up to an additional €2bn over the next two years....
...But analysts at Jefferies said that worries about the company’s “R&D productivity will take time to lift”, pointing to a lack of significant trial results expected in 2024 and growth tailing off for the...
...“We employ a consultancy to do our R&D claims for us because we haven’t got the time to fight the claims,” he said....
...Rani R. Raad, chief executive of IMI, said they would work closely with the family “as they deliver against their strategic objectives and growth ambitions”....
...Knocking down long-standing barriers to cross-border trade, making it easier to capture the opportunity of global economic growth through trade deals, better leveraging our capabilities in R&D and ensuring...
...AstraZeneca has invested heavily in R&D under Soriot’s tenure and has launched a string of blockbuster products including top-selling cancer drugs Tagrisso and Imfinzi, which brought in $1.6bn and $1.1bn...
...Companies will be even less likely to fund the search for new drugs in Europe if the payback is reduced, he said....
...Earlier this year, Samarco, Vale and BHP were ordered by a Brazilian court to pay R$47.6bn in compensation for the dam collapse. Both companies have said they would consider appealing....
International Edition